Zulresso
Chemical Name | brexanolone |
Dosage Form | Injectable (intravenous; 5 mg/mL) |
Drug Class | Modulators |
System | Nervous |
Company | Sage Therapeutics |
Approval Year | 2019 |
Indication
- Zulresso is indicated for the treatment of postpartum depression (PPD) in adults.